Fulgent Genetics Inc [FLGT] stock is trading at $16.65, up 7.28%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The FLGT shares have gain 2.52% over the last week, with a monthly amount glided 1.96%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Fulgent Genetics Inc [NASDAQ: FLGT] stock has seen the most recent analyst activity on December 07, 2023, when UBS initiated its Neutral rating and assigned the stock a price target of $35. Previously, Piper Sandler downgraded its rating to Neutral on December 08, 2022, and dropped its price target to $40. On November 18, 2022, Raymond James initiated with a Outperform rating and assigned a price target of $45 on the stock. Credit Suisse started tracking the stock assigning a Outperform rating and suggested a price target of $65 on August 25, 2022. In a note dated January 08, 2021, Credit Suisse downgraded an Underperform rating on this stock and revised its target price from $42 to $40.
Fulgent Genetics Inc [FLGT] stock has fluctuated between $14.57 and $25.11 over the past year. Currently, Wall Street analysts expect the stock to reach $45 within the next 12 months. Fulgent Genetics Inc [NASDAQ: FLGT] shares were valued at $16.65 at the most recent close of the market. An investor can expect a potential return of 170.27% based on the average FLGT price forecast.
Analyzing the FLGT fundamentals
Fulgent Genetics Inc [NASDAQ:FLGT] reported sales of 283.47M for the trailing twelve months, which represents a growth of 8.10%. Gross Profit Margin for this corporation currently stands at 0.36% with Operating Profit Margin at -0.26%, Pretax Profit Margin comes in at -0.18%, and Net Profit Margin reading is -0.15%. To continue investigating profitability, this company’s Return on Assets is posted at -0.04, Equity is -0.04 and Total Capital is -0.06. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 15.72 points at the first support level, and at 14.80 for the second support level. However, for the 1st resistance point, the stock is sitting at 17.17, and for the 2nd resistance point, it is at 17.69.
Ratios To Look Out For
For context, Fulgent Genetics Inc’s Current Ratio is 4.85. As well, the Quick Ratio is 4.85, while the Cash Ratio is 0.76. Considering the valuation of this stock, the price to sales ratio is 1.81, the price to book ratio is 0.45.
Transactions by insiders
Recent insider trading involved Kim Paul, CFO and Treasurer, that happened on Mar 05 ’25 when 100000.0 shares were purchased. President and COO, Xie Jian completed a deal on Dec 03 ’24 to sell 1455.0 shares. Meanwhile, Chief Scientific Officer Gao Hanlin sold 1373.0 shares on Dec 03 ’24.
